These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22932322)

  • 1. State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
    Muchomba FM; Gearing RE; Simoni JM; El-Bassel N
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):490-8. PubMed ID: 22932322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.
    Gengiah TN; Moosa A; Naidoo A; Mansoor LE
    Int J Clin Pharm; 2014 Feb; 36(1):70-85. PubMed ID: 24129582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicide clinical trial adherence: insights for introduction.
    Woodsong C; MacQueen K; Amico KR; Friedland B; Gafos M; Mansoor L; Tolley E; McCormack S
    J Int AIDS Soc; 2013 Apr; 16(1):18505. PubMed ID: 23561044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.
    Carballo-Diéguez A; Balán IC; Brown W; Giguere R; Dolezal C; Leu CS; Marzinke MA; Hendrix CW; Piper JM; Richardson BA; Grossman C; Johnson S; Gomez K; Horn S; Kunjara Na Ayudhya RP; Patterson K; Jacobson C; Bekker LG; Chariyalertsak S; Chitwarakorn A; Gonzales P; Holtz TH; Liu A; Mayer KH; Zorrilla C; Lama J; McGowan I; Cranston RD
    PLoS One; 2017; 12(7):e0181607. PubMed ID: 28750059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.
    Amico KR
    Curr Opin HIV AIDS; 2012 Nov; 7(6):542-8. PubMed ID: 22964887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
    Bekker LG; Roux S; Sebastien E; Yola N; Amico KR; Hughes JP; Marzinke MA; Hendrix CW; Anderson PL; Elharrar V; Stirratt M; Rooney JF; Piwowar-Manning E; Eshleman SH; McKinstry L; Li M; Dye BJ; Grant RM;
    Lancet HIV; 2018 Feb; 5(2):e68-e78. PubMed ID: 28986029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol.
    Jin X; Wang H; Li H; Chu Z; Zhang J; Hu Q; Lv W; Huang X; Chen Y; Wang H; He X; Zhang L; Hu Z; Bao R; Li S; Ding H; Geng W; Jiang Y; Shang H; Xu J;
    BMC Public Health; 2020 Jul; 20(1):1160. PubMed ID: 32709230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on Pre-Exposure Prophylaxis Regimens among Men Who Have Sex with Men: A Prospective Cohort Study.
    Wu D; Tao H; Dai J; Liang H; Huang A; Zhong X
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818006
    [No Abstract]   [Full Text] [Related]  

  • 11. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-exposure Prophylaxis Use and Medication Adherence Among Men Who Have Sex With Men: A Systematic Review of the Literature.
    Maxwell S; Gafos M; Shahmanesh M
    J Assoc Nurses AIDS Care; 2019; 30(4):e38-e61. PubMed ID: 31241514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability in microbicide and PrEP trials: current status and a reconceptualization.
    Mensch BS; van der Straten A; Katzen LL
    Curr Opin HIV AIDS; 2012 Nov; 7(6):534-41. PubMed ID: 23032737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
    Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
    AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological lessons from clinical trials and the future of microbicide research.
    van der Straten A; Montgomery ET; Hartmann M; Minnis A
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):89-102. PubMed ID: 23184582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antiretroviral chemoprophylaxis: current status.
    Baeten J; Celum C
    Curr Opin HIV AIDS; 2012 Nov; 7(6):514-9. PubMed ID: 22964886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials.
    Ferrer RA; Morrow KM; Fisher WA; Fisher JD
    AIDS Care; 2010 Aug; 22(8):997-1005. PubMed ID: 20552466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study.
    Qu D; Zhong X; Xiao G; Dai J; Liang H; Huang A
    Int J Infect Dis; 2018 Oct; 75():52-59. PubMed ID: 30125688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
    Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R
    J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.
    Minnis AM; Gandham S; Richardson BA; Guddera V; Chen BA; Salata R; Nakabiito C; Hoesley C; Justman J; Soto-Torres L; Patterson K; Gomez K; Hendrix CW
    AIDS Behav; 2013 Feb; 17(2):737-47. PubMed ID: 23065145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.